Vitamin D and Immunosenescence in Older Long-Term Care Residents
老年长期护理居民的维生素 D 和免疫衰老
基本信息
- 批准号:8521040
- 负责人:
- 金额:$ 20.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-15 至 2015-08-31
- 项目状态:已结题
- 来源:
- 关键词:25-hydroxyvitamin DAccident and Emergency departmentAcute respiratory infectionAgeAgingAntibodiesAntigen PresentationAreaAttenuatedAwardB-LymphocytesBiological AssayBiologyCholecalciferolClinicalClinical ImmunologyClinical InvestigatorClinical TrialsColoradoDataDendritic CellsDevelopment PlansDoseElderlyEmergency MedicineEnvironmentFacultyFellowshipFundingGeriatricsHeadHealth Care CostsHemagglutinationHerpes zoster diseaseHerpesvirus Type 3HomingHospitalizationHost DefenseImmune responseImmunityImmunologyIncidenceInfectionInfectious Disease ImmunologyInfluenzaInfluenza vaccinationInterferonsInterventionK-Series Research Career ProgramsLeadLearningLifeLife ExpectancyLong-Term CareLymphoidMeasuresMediatingMediator of activation proteinMedicineMemoryMentorsMentorshipMorbidity - disease rateMyronNatural ImmunityNursing HomesObservational StudyOralOrganPediatricsPredispositionPreventionPublic HealthResearchResearch DesignResearch PersonnelRiskRoleSample SizeSerumSeveritiesSiteSupplementationT cell responseT-LymphocyteTimeTrainingUnited States National Institutes of HealthUniversitiesVaccinationVaccinesVisitVitamin DVitamin D Deficiencyage relatedantimicrobial peptidecareercareer developmentcell mediated immune responsecohortenzyme linked immunospot assayexperiencehealth care service utilizationimmune functionimmunogenicityimmunosenescenceimprovedinfluenza virus vaccineinnovationpathogenpilot trialpreventprofessorprospectivereceptorrespiratoryresponseseasonal influenzasenescencetraffickingvaccine effectiveness
项目摘要
DESCRIPTION (provided by applicant): Candidate: Adit Ginde, MD, MPH is an Assistant Professor of Emergency Medicine at University of Colorado Denver (UCD). He has prior MPH and research fellowship training, and his early research career has focused on observational studies in vitamin D and acute respiratory infection (ARI). He seeks to transition from his institutional KL2 Award to this Beeson Career Development Award to focus on the role of vitamin D in the age related decline in immune function and specifically, response to infection and vaccine in older adults. Mentors/Environment: The primary mentor, Robert Schwartz, MD, is the Division Head of Geriatric Medicine and Director of the UCD Center on Aging. The co-mentor for immunology, Myron Levin, MD, is Professor of Medicine and Pediatrics at UCD, whose research has focused on characterizing and improving response to influenza and herpes zoster vaccines. Both are well-funded NIH clinical investigator and have mentored numerous junior faculty to successful independent careers in aging and immunology research. Training: The proposed Beeson career development plan builds on prior experience from fellowship and early career development awards to focus on three primary topical areas that require additional training: 1) Translational and Interventional Study Design; 2) Aging/Nursing Home Research; and 3) Clinical Immunology. Dr. Ginde proposes intensive topical mentorship, focused coursework/seminars, and mentored research. Research: Infections are common in older adults resulting in increased healthcare utilization and morbidity. Vaccines improve host defense against pathogens and reduce the incidence, severity, and duration of common infections. However, the immune response to infectious pathogens and effectiveness of vaccines decline with advancing age. The ability of vitamin D supplementation to improve response to pathogens and vaccines in older adults has not been previously investigated in a clinical trial. In the context of a clinical trial of monthly oral high-dose vitamin D3 supplementation vs. standard dose vitamin D3 supplementation in older (age > 60 years) long-term care residents, we propose the following specific aims: 1) Measure the efficacy of high dose monthly oral high-dose vitamin D3 supplementation (equivalent to 3,000-4,000 IU/day) compared to standard dose vitamin D3 supplementation (400-1,000 IU/day) in prevention of ARIs in 200 older (age ?? 60 years) long-term care residents; 2) Determine the difference in specific humoral immune response to the inactive seasonal influenza vaccine by vitamin D3 supplementation dose and pre-vaccination serum 25- hydroxyvitamin D levels; 3) Determine the difference in specific cell-mediated immune response to the live, attenuated zoster vaccine by vitamin D3 supplementation dose and pre-vaccination 25-hydroxyvitamin D levels. Summary: This innovative research plan; strong mentorship from geriatrics, infectious disease, immunology, and vaccine experts; and proposed career development experience will help Dr. Ginde become a leading investigator of interventions to improve immunosenescence and reduce the burden of infection in older adults.
描述(由申请人提供): 候选人:Adit Ginde,医学博士、公共卫生硕士,是科罗拉多大学丹佛分校 (UCD) 急诊医学助理教授。他之前接受过公共卫生硕士和研究奖学金培训,他的早期研究生涯主要集中在维生素 D 和急性呼吸道感染 (ARI) 的观察性研究。他寻求从机构 KL2 奖过渡到 Beeson 职业发展奖,重点关注维生素 D 在与年龄相关的免疫功能下降中的作用,特别是老年人对感染和疫苗的反应。导师/环境:主要导师 Robert Schwartz 医学博士是老年医学部门负责人兼 UCD 老龄化中心主任。免疫学联合导师迈伦·莱文 (Myron Levin) 医学博士是都柏林大学医学和儿科教授,其研究重点是表征和改善对流感和带状疱疹疫苗的反应。两人都是资金雄厚的 NIH 临床研究员,并指导了许多初级教师在衰老和免疫学研究领域取得了成功的独立职业生涯。培训:拟议的 Beeson 职业发展计划以奖学金和早期职业发展奖项的先前经验为基础,重点关注需要额外培训的三个主要主题领域:1)转化和介入研究设计; 2)老龄化/疗养院研究; 3) 临床免疫学。金德博士建议加强专题指导、重点课程/研讨会和指导研究。研究:感染在老年人中很常见,导致医疗保健利用率和发病率增加。疫苗可以提高宿主对病原体的防御能力,并减少常见感染的发生率、严重程度和持续时间。然而,对传染性病原体的免疫反应和疫苗的有效性随着年龄的增长而下降。补充维生素 D 改善老年人对病原体和疫苗反应的能力此前尚未在临床试验中进行过研究。在对老年(年龄 > 60 岁)长期护理居民进行每月口服高剂量维生素 D3 补充剂与标准剂量维生素 D3 补充剂的临床试验的背景下,我们提出以下具体目标:1) 衡量每月高剂量口服高剂量维生素 D3 补充剂(相当于 3,000-4,000 IU/天)与标准剂量维生素 D3 补充剂(400-1,000 IU/天)相比IU/天)用于预防 200 名老年人(年龄 60 岁)长期护理居民的 ARI; 2)通过维生素D3补充剂量和接种前血清25-羟基维生素D水平确定对非活性季节性流感疫苗的特异性体液免疫反应的差异; 3) 通过维生素 D3 补充剂量和疫苗接种前 25-羟基维生素 D 水平确定对带状疱疹减毒活疫苗的特异性细胞介导免疫反应的差异。摘要:本次创新研究计划;来自老年病学、传染病、免疫学和疫苗专家的强有力指导;拟议的职业发展经验将帮助金德博士成为改善免疫衰老和减轻老年人感染负担的干预措施的主要研究者。
项目成果
期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Has the time for advanced pre-hospital care of severe sepsis finally arrived?
严重脓毒症院前高级救治的时代终于到来了吗?
- DOI:
- 发表时间:2012-12-15
- 期刊:
- 影响因子:24.7
- 作者:Ginde, Adit A;Moss, Marc
- 通讯作者:Moss, Marc
Reply to: Analysis Leads to Unreliable Results in Study of Vitamin D and Acute Respiratory Infection.
回复:维生素 D 与急性呼吸道感染研究的分析导致结果不可靠。
- DOI:
- 发表时间:2017-05
- 期刊:
- 影响因子:6.3
- 作者:Ginde, Adit A;Blatchford, Patrick
- 通讯作者:Blatchford, Patrick
Increasing critical care admissions from U.S. emergency departments, 2001-2009.
2001-2009 年美国急诊科重症监护入院人数增加。
- DOI:
- 发表时间:2013-05
- 期刊:
- 影响因子:8.8
- 作者:Herring, Andrew A;Ginde, Adit A;Fahimi, Jahan;Alter, Harrison J;Maselli, Judith H;Espinola, Janice A;Sullivan, Ashley F;Camargo Jr, Carlos A
- 通讯作者:Camargo Jr, Carlos A
Electronic communication capabilities of residential care facilities at times of transition.
过渡时期住宅护理设施的电子通信能力。
- DOI:
- 发表时间:2014-07
- 期刊:
- 影响因子:6.3
- 作者:Burke, Robert E;Jones, Christine D;Levy, Cari;Ginde, Adit A
- 通讯作者:Ginde, Adit A
The role of vitamin D in prevention and treatment of infection.
维生素 D 在预防和治疗感染中的作用。
- DOI:
- 发表时间:2013-08
- 期刊:
- 影响因子:0
- 作者:Gunville, Cameron F;Mourani, Peter M;Ginde, Adit A
- 通讯作者:Ginde, Adit A
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Adit A. Ginde其他文献
Adit A. Ginde的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Adit A. Ginde', 18)}}的其他基金
Implementation and Real-World Effectiveness of Monoclonal Antibodies to Treat High-Risk Outpatients with COVID-19
单克隆抗体治疗高危门诊 COVID-19 患者的实施和实际有效性
- 批准号:
10342493 - 财政年份:2018
- 资助金额:
$ 20.66万 - 项目类别:
Vitamin D and Immunosenescence in Older Long-Term Care Residents
老年长期护理居民的维生素 D 和免疫衰老
- 批准号:
8331468 - 财政年份:2011
- 资助金额:
$ 20.66万 - 项目类别:
Vitamin D and Immunosenescence in Older Long-Term Care Residents
老年长期护理居民的维生素 D 和免疫衰老
- 批准号:
8184736 - 财政年份:2011
- 资助金额:
$ 20.66万 - 项目类别:
Vitamin D and Immunosenescence in Older Long-Term Care Residents
老年长期护理居民的维生素 D 和免疫衰老
- 批准号:
8325814 - 财政年份:2011
- 资助金额:
$ 20.66万 - 项目类别:
Vitamin D and Immunosenescence in Older Long-Term Care Residents
老年长期护理居民的维生素 D 和免疫衰老
- 批准号:
8403437 - 财政年份:2011
- 资助金额:
$ 20.66万 - 项目类别:
相似海外基金
A Point-of-Care Test for Rapid Diagnosis of Valley Fever
快速诊断谷热的即时测试
- 批准号:
10759985 - 财政年份:2023
- 资助金额:
$ 20.66万 - 项目类别:
Point-of-care system to assess the risk of trauma-induced acute respiratory distress syndrome
用于评估创伤引起的急性呼吸窘迫综合征风险的护理点系统
- 批准号:
10594793 - 财政年份:2023
- 资助金额:
$ 20.66万 - 项目类别:
Identifying patient subgroups and processes of care that cause outcome differences following ICU vs. ward triage among patients with acute respiratory failure and sepsis
确定急性呼吸衰竭和脓毒症患者在 ICU 与病房分诊后导致结局差异的患者亚组和护理流程
- 批准号:
10734357 - 财政年份:2023
- 资助金额:
$ 20.66万 - 项目类别:
Physiologic Predictors of Respiratory Failure in Patients Presenting with Dyspnea
呼吸困难患者呼吸衰竭的生理预测因素
- 批准号:
10606999 - 财政年份:2023
- 资助金额:
$ 20.66万 - 项目类别:
Dose escalation clinical trial of high-dose oral montelukast to inform future RCT in children with acute asthma exacerbations
大剂量口服孟鲁司特的剂量递增临床试验为哮喘急性发作儿童的未来随机对照试验提供信息
- 批准号:
10649012 - 财政年份:2023
- 资助金额:
$ 20.66万 - 项目类别: